Detalles de la búsqueda
1.
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.
J Clin Immunol
; 36(7): 700-12, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582171
2.
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.
J Clin Immunol
; 36(6): 571-82, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27220317
3.
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
J Peripher Nerv Syst
; 18(4): 321-30, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24725024
4.
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
J Allergy Clin Immunol
; 130(4): 951-7.e11, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22846381
5.
Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
J Clin Immunol
; 37(8): 739-740, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28875256
6.
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.
Immunotherapy
; 14(4): 215-224, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931880
7.
Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.
J Clin Immunol
; 31(3): 323-31, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21424824
8.
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents.
Immunotherapy
; 11(12): 1057-1065, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31268374
9.
Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies.
Immunotherapy
; 11(5): 397-406, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626238
10.
Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability.
Immunotherapy
; 8(10): 1175-86, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27468136
11.
Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study.
Immunotherapy
; 7(7): 753-63, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865232
12.
Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency.
J Clin Immunol
; 26(4): 388-95, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16705486
Resultados
1 -
12
de 12
1
Próxima >
>>